scholarly journals Definition of the Primary Structure of Hepatitis B Virus (HBV) pre-S Hepatocyte Binding Domain Using Random Peptide Libraries

Virology ◽  
1997 ◽  
Vol 237 (2) ◽  
pp. 319-326 ◽  
Author(s):  
Felicity D'Mello ◽  
Charalambos D. Partidos ◽  
Michael W. Steward ◽  
Colin R. Howard
2021 ◽  
Vol 12 ◽  
Author(s):  
Hyein Jeong ◽  
Yu-Min Choi ◽  
Hyejun Seo ◽  
Bum-Joon Kim

A coronavirus SARS-CoV-2, which has caused the pandemic viral pneumonia disease COVID-19, significantly threatens global public health, highlighting the need to develop effective and safe vaccines against its infection. In this study, we developed a novel DNA vaccine candidate against SARS-CoV-2 by expressing a chimeric protein of its receptor-binding domain (RBD) fused to a 33-bp sequence (11 aa) from the hepatitis B virus (HBV) preS1 region with a W4P mutation (W4P-RBD) at the N-terminal region and evaluated its immunogenicity. In vitro transfection experiments in multiple cell lines demonstrated that W4P-RBD vs. wild-type RBD protein (W-RBD) led to enhanced production of IL-6 and TNFα at the transcription and translation levels, suggesting the adjuvant potential of N-terminal HBV preS1 sequences for DNA vaccines against SARS-CoV-2. W4P-RBD also led to enhanced production of IgG and IgA, which can neutralize and block SARS-CoV-2 infection in both blood sera and bronchoalveolar lavage (BAL) fluid from the lung in vaccinated mice. Additionally, W4P-RBD led to an enhanced T-cell-mediated cellular immune response under S1 protein stimulation. In summary, W4P-RBD led to robust humoral and cell-mediated immune responses against SARS-CoV-2 in vaccinated mice, highlighting its feasibility as a novel DNA vaccine to protect against SARS-CoV-2 infection.


1993 ◽  
Vol 67 (4) ◽  
pp. 2376-2380 ◽  
Author(s):  
A Bertoletti ◽  
F V Chisari ◽  
A Penna ◽  
S Guilhot ◽  
L Galati ◽  
...  

Intervirology ◽  
2009 ◽  
Vol 52 (6) ◽  
pp. 321-322 ◽  
Author(s):  
Sang Hoon Ahn ◽  
Lilly Yuen ◽  
Peter Revill

2003 ◽  
Vol 98 ◽  
pp. S90-S91
Author(s):  
Guilherme Macedo ◽  
Susana Lopes ◽  
Fernando Araujo ◽  
Fatima Carneiro ◽  
Tavarela Veloso

1997 ◽  
Vol 324 (2) ◽  
pp. 523-528 ◽  
Author(s):  
Nils. B ADEY ◽  
Brian. K KAY

Peptides isolated from combinatorial libraries typically interact with, and thus help to characterize, biologically relevant binding domains of target proteins. To characterize the binding domains of the focal adhesion protein vinculin, vinculin-binding peptides were isolated from two phage-displayed random peptide libraries. Altogether, five non-similar vinculin-binding peptides were identified. Despite the lack of obvious sequence similarity between the peptides, binding and competition studies indicated that all five interact with the talin-binding domain of vinculin and do not disrupt the binding of α-actinin or paxillin to vinculin. The identified peptides and talin bind to vinculin in a comparable manner; both bind to immobilized vinculin, but neither binds to soluble vinculin unless the C-terminus of vinculin has been deleted. An analysis of amino acid variants of one of the peptides has revealed three non-contiguous motifs that also occur in the region of talin previously demonstrated to bind vinculin. Amino acid substitutions within a 127-residue segment of talin capable of binding vinculin confirmed the importance of two of the motifs and suggest that residues critical for binding are within a 16-residue region. This study demonstrates that the vinculin-binding peptides interact with vinculin in a biologically relevant manner and represent an excellent tool for further study of the biochemistry of vinculin.


Sign in / Sign up

Export Citation Format

Share Document